期刊文献+

药物性肝损伤的发病机制 被引量:11

Pathogenesis of drug-induced liver injury
原文传递
导出
摘要 药物性肝损伤是指药物或其代谢产物引起的肝功能异常或肝脏对药物及代谢产物的超敏反应所致的疾病,分为本质性肝损伤和特异性肝损伤两大类,与细胞色素P450(CYP450)酶系统相关的药物性肝损伤是特异性肝损伤发生最主要的机制,药物或其代谢产物的直接损伤、过敏反应、免疫系统激活和氧化应激造成线粒体损伤也是药物性肝损伤发生的主要因素之一。 Drag induced liver injury refers to liver function abnormalities caused by drugs or their metabolites or liver disease caused by hypersensitivity to the drug and their metabolites. It can be divided into the essence of liver injury and liver specific injury, mechanism of specific liver injury is the most important with cytochrome P450 (CYP450) of hepatic injury related enzyme system, direct injury of drugs and their metabolites, allergic reactions, immune system activation, mitochondrial damage caused by oxidative stress, all of these are one of the main causes of dru^-induced liver iniurv.
作者 鲍中英
出处 《中华临床医师杂志(电子版)》 CAS 2015年第19期1-3,共3页 Chinese Journal of Clinicians(Electronic Edition)
关键词 药物性肝损伤 机制 Drug-induced liver injury Mechanism
  • 相关文献

参考文献15

  • 1Velayudham LS, Farrell CC. Drug-induced Cholestasis[J]. Expert opin drug Saf, 2003, 2(3): 287-304.
  • 2Lee WM. Aeetarninophen" and the U.S. Acute, liver Failure Study Group: lowering the risks of hepatic failure[J]. Hepatology, 2004, 40(1): 6-9.
  • 3squires RH Jr, Shneider BL, Bucuvalas J, et al. Liver failure in children; the first 348 patients in the pediatric acute liver failure study group[J]. J Pediatr, 2006, 148(5):652-658.
  • 4Jacqz-Aigrain E, Anderson BJ. Pain control: non-steroidal anti-inflammatory agents[J]. Semin Fetal Neonatal Med, 2006, 11(4): 251-259.
  • 5陈晓霞,杨海敏,姜娜.110例药物性肝炎的病因和临床分析[J].实用医技杂志,2008,15(13):1728-1730. 被引量:8
  • 6Lammert C, Bjornsson E, Niklasson A, et al. Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events[J]. Hepatology, 2010, 5 l: 615-620.
  • 7傅青春,吴银霞.药物性肝损伤的发病机制[J].医学与哲学(B),2013,34(10):14-16. 被引量:7
  • 8Chalasani N, Fontana PJ, Bonkovsky HL, et al. Drug Induced Liver Injury Network Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States[J]. Gastroenterology, 2008, 135(6): 1924-1934.
  • 9陈成伟.药物性肝损伤的发病机制及其处理[J].中华结核和呼吸杂志,2013,36(10):726-728. 被引量:25
  • 10Boelsterli UA, Lira PL. Mitochondrial abnorrnalities--a link to idiosyncratic drug hepatotoxicity?[J]. Toxieol Appl Pharmacol, 2007, 220(I): 92-107.

二级参考文献30

  • 1张涛,贾继东.107例药物性肝损害的病因和临床特点[J].肝脏,2005,10(3):174-176. 被引量:40
  • 2夏愔愔,詹思延.国内抗结核药物不良反应发生率的综合分析[J].中华结核和呼吸杂志,2007,30(6):419-423. 被引量:208
  • 3Watanabe I, Tomita A, Shimizu M, et al. A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus. Clin Pharmacol Ther, 2003, 73: 435-455.
  • 4Tujios S, Fontana RJ. Mechanisms of drug-induced liver injury:from bedside to bench. Nat Rev Gastroenterol Hepatol, 2011, 8:202-211.
  • 5Lucena MI, Garcia-Martin E, Andrade RJ, et al. Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury. Hepatology, 2010, 52:303-312.
  • 6Padda MS, Sanchez M, Akhtar A J, et al. Drug-induced cholestasis. Hepatology, 2011, 53: 1377-1387.
  • 7Hayashi PH. Causality assessment in drug-induced liver injury. Semin Liver Dis, 2009, 29: 348-356.
  • 8Chung W H, Hung S I, Chen Y T. Genetic predisposition of life?threatening anti epileptic - induced skin reactions[J]. Expert Opin Drug Saf,2010, 90): 15 - 21.
  • 9Russmann S,Jetter A, Kullak - Ublick G A. Pharmacogenetics of drug-induced liver injury[J]. Hepatology,2010,52(2) :748-761.
  • 10Han D,Dara L, Win Sv et al. Regulation of drug-induced liver inju?ry by signal transduction pathways: critical role of mitochondria[J]. Trends Pharmacol Sci,2013,34(4) :243-253.

共引文献63

同被引文献120

引证文献11

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部